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Med101 For Engineers: Sepsis is bad!
? Sepsis and septic shock in critical care:
–
 
Significant incidence rates (2-11% for severe sepsis and higher for all forms)
–
 
Mortality of 30-80% reported
–
 
Tight glucose control can reduce mortality in sepsis
–
 
Annual (est.) cost of $16.7 per year in U.S. [Angus et al, 2001, Crit
 
Care Med]
? Diagnosis is challenging and early treatment is beneficial
–
 
Gold Standard
 
= positive blood culture should precede treatment but takes 24-48 hours
–
 
Early goal directed therapy reduced mortality from 46-31% [Rivers et al, NEJM 2001]
–
 
Therefore other markers are often used: 
? Primarily inflammatory and acute immune response markers with 2-3 hour lag on diagnosis and/or results 
(TNFα, IL-6, IL-8, CRP and PCT) [Carrigan et al, Clin Chem 2004]
? Insulin sensitivity is significantly affected by sepsis – could it be a marker?
–
 
Low values indicating sepsis or high values indicating its lack of presence
–
 
Mechanisms not fully known but assumed related to counter-regulatory and stress response in 
illness, as well as pro-inflammatory immune response and drug therapy.
? Hypothesis: Could an Insulin Sensitivity marker provide a more accurate diagnostic and 
reduce the preventative use of (broad coverage) antibiotics?
Methods
? Retrospective Study:
–
 
143
 
patients under tight glucose control using SPRINT at 
Christchurch Hospital
–
 
113
 
w/o sepsis; 30
 
diagnosed with sepsis
–
 
Cohort comprises 26,000+ hours of data
? Each hour was given a: 
–
 
Sepsis score (ss) on a scale of 0 ? 4
–
 
Clinically validated model-based insulin sensitivity 
value (SI )
–
 
Simplified insulin sensitivity during periods of 
constant glucose level based on nutrition and 
insulin inputs (SSI )
? Patients with T1DM or T2DM were excluded
? Ethics approval from South Island Regional 
Ethics Committee (New Zealand).
Sepsis Score (ss)
? Strictly clinical metric
? Follows ACCP and SCCM 
guideline definitions of 1992 
and 2003 for sepsis diagnosis
? Includes both SIRS and SOFA 
scores to account for more 
than a single criteria
? Inotrope dosing included due 
to its common use in treating 
severe sepsis
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Insulin Sensitivity Metrics
? Model based insulin sensitivity (SI): 
–
 
Derived from fitting a dynamic model to the data
–
 
Model clinically validated in several glycaemic control studies and trials in critical 
care and vs. euglycaemic
 
clamp
–
 
Readily calculated in real-time by computer
? Simplified insulin sensitivity metric (SSI):
–
 
Matches the ISI of euglycaemic
 
clamp (ISI/G normalisation)
–
 
Valid during periods of relatively constant glucose levels 
–
 
Can be calculated by hand in real-time t
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Patients
? Retrospective data study
? T1DM and T2DM excluded if diagnosed
? Sepsis patients were all diagnosed by blood culture
Summary of Patient hours in each subset of the ICU cohort
Sepsis Non-Sepsis Total
Number of Patients
 
30
 
113
 
143
Total Hours
 
6,744
 
19,709
 
26,453
Total Hours where
 
2,036
 
5,493
 
7,529
dG/dt
 
~ 0 for SSI
ROC Results (for ss ≥
 
3)
? Model based (SI ):
–
 
Sensitivity = 78%
–
 
Specificity = 82%
–
 
Positive Prediction = 2.8%
–
 
Negative Prediction = 99.8%
–
 
SI Cutoff
 
= 8.5e-5
–
 
% Measurements < cutoff
 
= 15%
? Simple (SSI ):
–
 
Sensitivity = 69%
–
 
Specificity = 82%
–
 
Positive Prediction = 2.5%
–
 
Negative Prediction = 99.7%
–
 
Lower numbers of hours
Is SSI an effective metric?
? Good correlation at low 
cutoff values
? Spread at higher values 
above cutoff values
? Spread thus does not 
affect usefulness of 
simple metric (SSI ) as a 
negative predictor of 
sepsis in place of the 
model based metric (SI )
NB: I ≥
 
2U/hr
r = 0.82
Why not positive prediction?
? Any number of clinical causes 
of low insulin sensitivity
? Drug therapies can lower 
insulin sensitivity in survivors
? Mortality and lower insulin 
sensitivity may also go 
together (level of acuity)
? These results are from a study 
of steroids and insulin 
sensitivity in 53 Subarachnoid 
Haemorrhage patients 
? Positive prediction will require 
a way to filter out other causes 
of low insulin sensitivity
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Conclusions and Positive Prediction
? Both metrics provide negative prediction for/over a significant amount 
of the patient hours.
–
 
May thus reduce unnecessary preventative antibiotic use
? Both insulin sensitivity metrics can be readily available at bedside
–
 
SI requires a model and computation (e.g. PDA)
–
 
SSI requires a consistent and an effective glycaemic control protocol
? Positive prediction is ~0 because very low insulin sensitivity may be 
indicative of sepsis or a variety of other conditions and/or drug therapies
? Future necessities:
–
 
Improve cutoff
 
values and validate prospectively (tighter metric)
–
 
Better sepsis score?
–
 
Improve positive prediction via additional heuristics or symptoms in addition 
to insulin sensitivity to discriminate between sepsis and other conditions?
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